Subintimal vs. Intraplaque Coronary Rechanneling. Do Results Vary?

Coronary rechanneling is difficult by nature, and there are several techniques for it aimed at improving technical success. Some of these strategies entail the subintimal crossing of the occluded segment, while others entail intraplaque crossing, without leaving the true lumen. However, there is scarce or no information on the results of both strategies.

Researchers analyzed 75 consecutive patients undergoing angiography and optical coherence tomography (OCT) after rechanneling, who were included in the ISAR-OCT-CTO (Intracoronary Stenting and Angiographic Results – Optical Coherence Tomography for Chronic Total Occlusions) registry. The study endpoints were stenosis diameter, lumen loss, and rate of uncovered or malapposed struts.

Intraplaque rechanneling was used in 46 patients, while dissection and re-entry techniques were used in 29 patients.


Read also: Prosthesis Mismatch in Supra and Intra Annular valves.


There were no significant differences in terms of in-segment stenosis diameter (mean 36.9% vs. 31.2%; p = 0.656), in-stent late lumen loss (0.21 mm vs. 0.23 mm; p = 0.83), or in-segment late lumen loss (0.03 vs. 0.13; p = 0.39) between intraplaque vs. subintimal techniques.

The OCT imaging analysis showed comparable strut coverage (79.9% vs. 71.3%; p = 0.255) but much higher malapposition rates among patients in the subintimal technique group (6.6% vs. 13.6%; p < 0.001).

The use of dissection and re-entry techniques only predicted higher rates of strut malapposition.

Conclusion

Intraplaque and subintimal rechanneling techniques are associated with comparable mid-term angiographic results. Although the rate of uncovered struts is high after any rechanneling, it does not vary according to the technique used.

The only difference observed is a higher chance of strut malapposition with dissection and re-entry techniques.

Original title: Subintimal Versus Intraplaque Recanalization of Coronary Chronic Total Occlusions. Mid-Term Angiographic and OCT Findings From the ISAR-OCT-CTO Registry.

Reference: Erion Xhepa et al. J Am Coll Cardiol Intv 2019, Article in press.



Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

ACC-2025 Congress Second Day Key Studies

BHF PROTECT-TAVI (Kharbanda RK, Kennedy J, Dodd M, et al.)The largest randomized  trial carried out across 33 UK centers between 2020 and 2024, assessing...

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...

CRABBIS Trial: Comparison of Different Provisional Stenting Sequences

Provisional stenting (PS) is the gold standard for percutaneous coronary intervention (PCI) in most patients with coronary bifurcation lesions (CBL). Moreover, recent studies such...

Andromeda Trial: Meta-Analysis of Drug Coated Balloon vs. DES in Small Vessel DeNovo Lesions

The use of coronary stents vs plain old balloon angioplasty (POBA), has allowed to reduce recoil and limiting flow dissection which were major limitation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC-2025 Congress Second Day Key Studies

BHF PROTECT-TAVI (Kharbanda RK, Kennedy J, Dodd M, et al.)The largest randomized  trial carried out across 33 UK centers between 2020 and 2024, assessing...

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...

ACC 2025 | API-CAT: Reduced vs. Full Dose Extended Anticoagulation in Patients with Cancer Related VTE

The risk of cancer related recurrent venous thromboembolism (VTE) will drop over time, while bleeding risk will persist. At present, it is recommended we...